#blood-test

#blood-test

Cancer incidence rates are rising across generations, with no conclusive explanation provided yet.

Blood test for Alzheimer's risk could soon be as simple as testing cholesterol levels.

A new blood test showing 90% accuracy in diagnosing Alzheimer's disease in early stages offers hope for improved treatment.

A blood test can identify Alzheimer's disease more accurately than traditional methods.

A blood test could offer high accuracy in diagnosing Alzheimer's disease, potentially surpassing judgments by doctors and specialists.

It is crucial to use the blood test method for Alzheimer's diagnosis only in patients already displaying cognitive decline.

Pharmaceutical companies are actively developing blood tests for Alzheimer's, indicating an upcoming shift in diagnostic methods.

AlzPath's blood test for ptau217 offers early Alzheimer’s detection, crucial for timely treatment as new therapies develop.

A blood test for Alzheimer's disease shows 90% accuracy compared to cognitive tests and CT scans, revolutionizing diagnosis possibilities.

The FDA has approved a blood test for colon cancer screening, making it more accessible and potentially saving lives.

The FDA approved a new blood test for colon cancer screening in average-risk adults. This noninvasive test may improve screening rates and supplement colonoscopy screenings.

The FDA approved a new blood test, Shield, by Guardant Health, to screen for colon cancer, enhancing early detection and affordability.

The FDA approved a new blood test called 'Shield' by Guardant Health for early detection of colorectal cancer in at-risk individuals over 45, increasing chances of survival.

Blood test can detect 83% of colorectal cancer cases

FDA approval could offer a less invasive screening option

Blood test for colon cancer showed 83% accuracy in detecting cancers.

Colonoscopies remain the gold standard for colon cancer screening, detecting both tumors and precancerous growths.